Biocon Limited

Biocon Limited (BIOCON) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

biocon.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹402.00
Market cap
65,198 Cr
Stock P/E
156.6
P/B
1.75
Dividend yield
0.1%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales3,462 Cr3,954 Cr3,917 Cr3,433 Cr3,590 Cr3,821 Cr4,417 Cr3,942 Cr4,296 Cr4,173 Cr4,517 Cr4,336 Cr
Operating expenses (approx.)2,721 Cr3,027 Cr3,001 Cr2,813 Cr2,905 Cr3,070 Cr3,339 Cr3,193 Cr3,460 Cr3,340 Cr3,496 Cr3,489 Cr
EBITDA742 Cr927 Cr916 Cr620 Cr685 Cr752 Cr1,078 Cr749 Cr835 Cr834 Cr1,020 Cr847 Cr
OPM %21.4%23.4%23.4%18.1%19.1%19.7%24.4%19.0%19.4%20.0%22.6%19.5%
Other income158 Cr566 Cr49 Cr1,135 Cr33 Cr35 Cr37 Cr80 Cr93 Cr117 Cr53 Cr55 Cr
Interest248 Cr267 Cr227 Cr236 Cr226 Cr223 Cr212 Cr277 Cr272 Cr210 Cr232 Cr213 Cr
Depreciation389 Cr415 Cr407 Cr405 Cr420 Cr425 Cr436 Cr455 Cr473 Cr515 Cr513 Cr547 Cr
Profit before tax214 Cr808 Cr319 Cr1,146 Cr98 Cr156 Cr487 Cr97 Cr171 Cr-68 Cr248 Cr128 Cr
Tax %19.4%6.8%30.1%24.8%72.5%48.0%5.6%7.9%22.5%23.6%19.8%-7.2%
Net profit173 Cr753 Cr223 Cr862 Cr27 Cr81 Cr459 Cr89 Cr133 Cr-52 Cr199 Cr137 Cr
EPS (₹)₹1.05₹5.52₹1.13₹5.51₹-0.13₹0.21₹2.88₹0.26₹0.66₹1.08₹0.79₹0.87

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5,514 Cr6,367 Cr7,106 Cr8,184 Cr11,174 Cr14,756 Cr15,262 Cr16,927 CrSign in for TTM
Operating expenses (approx.)4,121 Cr4,764 Cr5,453 Cr6,214 Cr8,663 Cr11,457 Cr12,095 Cr13,472 CrSign in for TTM
EBITDA1,394 Cr1,603 Cr1,653 Cr1,970 Cr2,512 Cr3,299 Cr3,166 Cr3,455 CrSign in for TTM
OPM %25.3%25.2%23.3%24.1%22.5%22.4%20.7%20.4%Sign in for TTM
Other income144 Cr161 Cr255 Cr213 Cr376 Cr866 Cr1,208 Cr343 CrSign in for TTM
Interest71 Cr65 Cr58 Cr68 Cr419 Cr974 Cr897 Cr990 CrSign in for TTM
Depreciation448 Cr552 Cr715 Cr814 Cr1,113 Cr1,569 Cr1,687 Cr1,957 CrSign in for TTM
Profit before tax1,215 Cr1,186 Cr1,068 Cr983 Cr897 Cr1,525 Cr1,887 Cr448 CrSign in for TTM
Tax %17.5%26.6%20.7%21.5%28.3%14.9%24.2%17.7%Sign in for TTM
Net profit1,003 Cr871 Cr846 Cr772 Cr643 Cr1,298 Cr1,429 Cr369 CrSign in for TTM
EPS (₹)₹15.30₹6.32₹6.24₹5.44₹3.88₹8.55₹8.46₹2.82Sign in for TTM
Dividend payout %———-44.9%11.2%15.6%5.8%24.6%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital300 Cr600 Cr600 Cr600 Cr600 Cr600 Cr600 Cr811 Cr
Reserves5,798 Cr6,106 Cr7,026 Cr7,832 Cr17,267 Cr19,183 Cr21,044 Cr33,221 Cr
Borrowings————17,771 Cr15,730 Cr17,756 Cr14,825 Cr
Other liabilities6,094 Cr7,738 Cr10,896 Cr11,962 Cr11,783 Cr15,066 Cr13,329 Cr12,204 Cr
Total liabilities12,192 Cr14,444 Cr18,522 Cr20,394 Cr52,043 Cr56,071 Cr58,797 Cr63,651 Cr
Fixed assets (net)————7,535 Cr7,418 Cr8,708 Cr9,473 Cr
CWIP————2,588 Cr3,985 Cr4,102 Cr4,613 Cr
Investments————2,069 Cr1,000 Cr1,127 Cr1,779 Cr
Inventories————4,244 Cr4,944 Cr4,931 Cr6,086 Cr
Trade receivables————3,573 Cr6,231 Cr5,488 Cr5,987 Cr
Cash & bank————1,324 Cr1,234 Cr3,227 Cr2,417 Cr
Other assets12,192 Cr14,444 Cr18,522 Cr20,394 Cr30,711 Cr31,260 Cr31,214 Cr33,297 Cr
Total assets12,192 Cr14,444 Cr18,522 Cr20,394 Cr52,043 Cr56,071 Cr58,797 Cr63,651 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———1,177 Cr1,853 Cr2,954 Cr4,061 Cr1,994 Cr
Cash from investing———-1,699 Cr-14,282 Cr-1,004 Cr-234 Cr-2,082 Cr
Cash from financing———242 Cr13,049 Cr-2,333 Cr-1,854 Cr-924 Cr
Net cash flow———-277 Cr641 Cr-380 Cr2,004 Cr-812 Cr
Free cash flow (OCF − Capex)———-748 Cr126 Cr1,022 Cr1,718 Cr82 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %21.1%18.7%14.8%12.5%3.3%6.1%6.1%2.8%
ROE %14.8%11.2%9.7%7.7%2.1%4.0%3.7%1.1%
Debtor days————116154131129
Inventory days————484356420420
Days payable————454451557467
Cash conversion cycle————14659-781
Debt / equity————0.990.800.820.44
Current ratio————1.450.991.141.22
Net debt / EBITDA0.000.000.000.006.554.394.593.59

Compare with peers

Loading peers…